Prevalence of carboxy‐Δ8‐tetrahydrocannabiniol in antidoping samples

Documenti analoghi

• Evaluation of Minimum Reporting Limits to Determine In‐Competition Use of Stimulants
  di: Vinod S. Nair, et al.
  Pubblicazione: (2024)
• In Vitro Metabolism of Δ 8 ‐, Δ 9 ‐, and Δ 10 ‐THC in Human Hepatocytes: Distinct Δ 10 ‐THC Biotransformation and Implications for Drug Testing
  di: Robert Kronstrand, et al.
  Pubblicazione: (2026)
• Assessing EPO stability in urine and comparing recombinant EPO detectability in matched urine, venous serum, and capillary serum following a controlled epoetin alfa administration
  di: Geoffrey D. Miller, et al.
  Pubblicazione: (2024)
• Interest of hair tests to discriminate a tail end of a doping regimen from a meat contamination in case of challenging an antidoping rule violation. III. Case report involving boldenone
  di: Pascal Kintz, et al.
  Pubblicazione: (2024)
• Detecting EPO in Microvolumetric Capillary Serum Shipped at Ambient Temperature for Antidoping Testing
  di: Geoffrey D. Miller, et al.
  Pubblicazione: (2024)